Effects of notogisenoside on cogniyive impairment,oxidative stress and cognition related genes in rats with chronic cerebral ischemia

ZHAO Jiang-min,XIAO Jun-jie,SHAN Sheng-dao,GU Qin,JIANG Du-du,WANG Qin-ying,YU Min,ZHAN Qing
DOI: https://doi.org/10.3969/j.issn.1672-9248.2009.06.003
2009-01-01
Abstract:Objective To study the effects and mechanisms of notogisenoside on cognitive impairment in rats with chronic cerebral ischemia.Methods Thirty adult Wistar rats were randomly divided into sham operation group(SH group),ischemia group(2-VO group) and notogisenodide treatment group(2-VOtreat group).After 6 weeks,cognitive capability,the concentrations of MDA and SOD,expressions of NMADR and γ-aminobutyric acid receptor mRNA in brain tissue were measured. Results The times of electroshock in SH group was 68.3±3.46,which was less than 90.2±5.37 in 2-VO group(P<0.05) and 80.7±2.35 in 2-VOtreat group(P<0.05).The concentration of MDA in SH group was3.82±0.47 μmol/mg.prol lower than 8.79±0.51 μmol/mg.prol in 2-VO group(P<0.05) and 6.71±0.24 μmol/mg.prol(P<0.05) in 2-VOtreat group. The concentration of SOD in SH group was 98.73±5.49 U/mg.prol higher than 67.68±4.93 U/mg.prol in -VO group(P<0.05) and 81.09±6.75 U/mg.prol in 2-VOtreat group(P<0.05).The expressions of NMDAR and γ-aminobutyric acid receptor mRNA were significantly decreased in 2-VO group and 2-VOtreat group compared with SH group(P<0.05). And the expressions of NMDAR and γ-aminobutyric acid receptor mRNA were obviously decreased in 2-VO group compared with 2-VOtreat(P<0.05). Conclusions Notogisenoside treatment can improve cognitive impairment induced by chronic cerebral ischemia through decreasing oxidative stress damage and improving the expressions of cognition related genes as NMDAR and γ-aminobutyric acid receptor mRNA.
What problem does this paper attempt to address?